Poseida Therapeutics Inc
NASDAQ:PSTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Poseida Therapeutics Inc
NASDAQ:PSTX
|
US |
|
N
|
Nampak Ltd
XBER:NNZA
|
ZA |
|
C
|
Ctac NV
XBER:TAC
|
NL |
|
H
|
Huntington Bancshares Inc
SWB:HU3
|
US |
|
F
|
First Majestic Silver Corp
DUS:FMV
|
CA |
|
C
|
Consolidated Edison Inc
XBER:EDC
|
US |
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
Energy of Minas Gerais Co
BOVESPA:CMIG4
|
BR |
|
Axcelis Technologies Inc
NASDAQ:ACLS
|
US |
|
Nel ASA
F:D7G
|
NO |
|
B
|
BayWa AG
DUS:BYW6
|
DE |
|
R
|
Ramkhamhaeng Hospital PCL
SET:RAM
|
TH |
|
Novo Nordisk A/S
LSE:0TDD
|
DK |
|
C
|
Criteo SA
SWB:CI5A
|
FR |
|
Woodside Energy Group Ltd
ASX:WDS
|
AU |
|
Koninklijke Ahold Delhaize NV
MIL:1AD
|
NL |
|
S
|
secunet Security Networks AG
DUS:YSN
|
DE |
|
H
|
Heidelberger Beteiligungsholding AG
DUS:IPOK
|
DE |
|
W
|
Wolters Kluwer NV
XMUN:WOSB
|
NL |
|
NGK Spark Plug Co Ltd
F:NGK
|
JP |
|
A
|
Actic Group AB
F:8XA
|
SE |
|
Bank Rakyat Indonesia (Persero) Tbk PT
F:BYR
|
ID |
|
Tetra Tech Inc
NASDAQ:TTEK
|
US |
|
T
|
thyssenkrupp AG
XBER:TKA1
|
DE |
Bankruptcy Probability
Poseida Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Poseida Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Poseida Therapeutics Inc
NASDAQ:PSTX
|
925.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Poseida Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Poseida Therapeutics Inc has total debt of 58.9m USD. This includes both short-term (0 USD) and long-term (58.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
